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The paper of Rasyid et al. (2009) in this issue of Acta Ortho-
paedica addresses a problem that is important for those who 
treat bone and joint infections in developing countries, but 
increasingly also in so-called western countries. The paper 
is interesting and helpful for all surgeons who have to make 
antibiotic-loaded beads and spacers by themselves. This is 
necessary  when  commercially  produced  bone  cement  and 
beads are not available, or when the antibiotic in the PMMA 
is not effective due to resistance of the causative bacteria. The 
paper is based on a recent thesis from the research group of the 
Department of Biomedical Engineering at the University of 
Groningen, and is part of a series of publications about basic 
and clinical research on antibiotic-loaded cement and other 
biomaterials (Belt van de 2001, Hendriks 2003, Neut 2003, 
Ensing 2006, Engelsman 2009, Rasyid 2009). 
When gentamicin-loaded bone cement (Refobacin-Palacos) 
became available in Germany in the 1970s, efforts to treat 
osteomyelitis by filling the debrided cavity with solid plugs of 
antibiotic-loaded bone cement were not successful in patients 
in  France  and  Germany,  nor  in  animal  experiments  in  the 
Mayo Clinics (Vidal and Allieu 1969, Voorhoeve and Stöhr 
1973, Jenny et al. 1977, Fitzgerald 1983). Thus, Klaus Klemm 
started to make hand-made beads in his infection unit in the 
BG Unfallklinik in Frankfurt (Klemm 1993). The argument at 
that time for developing beads instead of solid cement plugs 
was that the debrided osteomyelitic cavities had to secrete 
freely—and it was not the increase in surface area-volume 
ratio, as is the accepted explanation for improved effective-
ness nowadays. The Kulzer company (Wehrheim, Germany), 
the producer of Refobacin-Palacos, developed the production 
of gentamicin-PMMA beads (Septopal) in the seventies. Sep-
topal beads have now been on the market for more then 30 
years, a remarkably long time for a pharmacological prod-
uct. This shows that the gentamicin-PMMA beads are still a 
unique product; they are needed in clinical practice and there 
is no good alternative when there is a requirement for local 
antibiotic treatment. Over the first 25 years, Septopal was dis-
tributed in most countries of Europe by Merck (Darmstadt, 
Germany), and nowadays it is distributed by Biomet (Biomet 
Europe, Berlin, Germany). It is still not accepted by the FDA 
in the US. 
One of the arguments against the use of antibiotic-loaded 
beads is the lack of proof of effectivity in good randomized 
clinical trials (RCTs). The most cited RCT was performed in 
the US in an attempt to get FDA approval, in 380 patients with 
osteomyelitis: systemic antibiotic treatment versus gentamicin 
beads. However, the protocol was violated because surgeons 
worried about withholding systemic antibiotics from patients 
who were treated with beads. In this trial, however, the costs 
were lower when beads were used, and there were less sys-
temic adverse events with antibiotics when local antibiotics 
were used (as compared to treatment with systemic antibi-
otics) (Blaha et al. 1993). Another RCT in the US studied 
the treatment of infected total hip and knee prostheses in 28 
patients, comparing 6 weeks of local treatment with gentami-
cin-PMMA beads with systemic antibiotic therapy. No statisti-
cally significant difference in infection healing was found, but 
that could have been due to the fact that the reimplantations 
in both groups were performed without the use of antibiotic in 
the bone cement (Nelson et al. 1993). 
An RCT was even performed in a developing country. This 
rarely cited study was done in an isolated Himalayan region of 
Nepal. Lars Lindberg (at that time from Kristianstad, Sweden) 
and  Margareta  Höök  treated  45  patients  with  debridement 
followed by the use of gentamicin beads or open treatment 
package of the debrided cavity (Höök and Lindberg 1987). 
The randomization was, however, imperfect due to the experi-
ence that “the immediate good results with gentamicin beads 
were so conspicuous that it was impossible to withhold this 
treatment from the children and the severe cases”, as they 
stated. Finally, I started an RCT in 1977, comparing genta-
micin-PMMA beads with suction drainage and systemic anti-
biotics in osteomyelitis and infected total hip. The trial was 
stopped after 27 patients because of the advantages of the bead 
therapy regarding nurses’ workload, primary wound healing, 
and avoidance of superinfection compared to suction drainage 
(Walenkamp 1983).
In the developing countries surgeons also became aware of 
the benefit of local antibiotic treatment of bone infections. The 
Septopal beads were, however, too expensive and surgeons 
had to look for alternative solutions. Beads made of plaster of 
Paris were an important alternative in the beginning.
The use of plaster of Paris in bone defects had been known 
since  1892,  when Trendelenburg  in  Bonn  (Germany)  filled 
bone defects (Peltier 1961). Admixture of gentamicin in plaster 
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in the treatment of bone infections  (Mackey et al. 1982), and 
antibiotic-loaded plaster of Paris pellets were used in several 
clinics, e.g. in  France (Berck Plage, Paris), Algeria, and India. 
For  many  years,  a  group  of  Dutch  orthopedic  surgeons 
used preformed gentamicin-containing plaster of Paris beads 
during their visits to Indonesia and Africa; these were made by 
a pharmacist at the hospital in Arnhem (Sorge et al. 1989). So 
gentamicin-loaded plaster of Paris was one of the first applica-
tions of resorbable antibiotic carriers, but the results were not 
excellent and its use was not widespread in Europe. A com-
mercial variant with tobramycin has been available for a few 
years (Chang et al. 2007).
The production by orthopedic surgeons in Indonesia of hand-
made beads was originally done by mixing bone cement with 
fosfomycin, an antibiotic often used in developing countries 
(Rasyid 2009). They formed beads of 1.5–3 cm diameter by 
hand. These relative large beads have a smaller surface area to 
volume ratio (1–1.5 cm-1) than Septopal beads (8.6 cm -1), so 
the release is worse. The paper of Rasyid et al. describes how 
a method can be developed to create hand-made gentamicin-
loaded PMMA beads with very good pharmacokinetic prop-
erties in combination with substantially reduced costs when 
compared with the commercially available beads (Septopal): 
112 USD instead of 350 USD.
These authors used an elegant method to increase the anti-
biotic release: simply the reduction of the monomer content 
by 50%, which causes large pores in the incompletely polym-
erized polymer particles. Porosity is one of the most impor-
tant factors in the process of sustained release of bone cement   
(Belt van de et al. 2000). In Septopal beads, the porosity is 
increased by the addition of glycine as a filler (which gets very 
little mention in the product information). Rasyid et al. used 
another filler by admixing the polymer with polyvinylpyrrol-
idone (PVP), the second reason for improvement of the poros-
ity and therefore of the antibiotic release. 
In western countries, improvement of antibiotic release from 
bone cement is also important. Spacers have a low surface 
area to volume ratio, resulting in a limited and often insuf-
ficient release of antibiotic (Greene et al. 1998, Walenkamp 
2007, Moojen et al. 2008). In the literature, spacers are mostly 
described as being effective in the treatment of infected pros-
theses and osteomyelitis defects, but there appears to be an 
important publication bias: all results are good. The release 
of  antibiotics  from  spacers  is  much  less  than  from  beads, 
resulting in suboptimal local antibiotic concentrations. This 
could largely be improved by changing the bone cement, as 
described in the thesis of Rasyid (2009) and the article of 
Rasyid et al. (2009).
Antibiotic-loaded beads are hand-made in the US because 
Septopal is not accepted by the FDA. Most surgeons in the US 
use tobramycin with Simplex bone cement in hand-making 
beads (Patzakis et al. 1993, Ostermann et al. 1995). In Europe, 
the need for hand-made beads has been on the increase for 10 
years due to more gentamicin resistance. Vancomycin is gen-
erally used to treat resistant strains of Staphylococcus aureus 
and S. epidermidis, possibly in combination with gentamicin 
(Taggart et al. 2002, Kelm et al. 2004, Stockley et al. 2008). 
Surgeons form the beads by hand and they are mostly held on 
a wire to form chains, facilitating removal. Self-made beads 
are generally not as good as commercial beads, however (Neut 
et al. 2003).
Self-made beads could be avoided by the “patient-matched 
service” of Biomet (Berlin Germany) that made it possible to 
order vancomycin-gentamicin PMMA beads for an individual 
patient, based on the resistance pattern of a causative agent 
(Pfefferle and Nies 2004). For 5 years, I treated a number of 
patients with these beads and the measured amount of release 
of vancomycin in the exudate appeared to be excellent. How-
ever, this service stopped suddenly without any warning in 
October 2008, and now we are also forced to make beads by 
hand. 
Finally, molds are helpful in the production of hand-made 
beads. Rasyid (2009) describes a template for a mold pro-
duced in Indonesia, and made of PTFE in stainless steel. Other 
molds  have been described from the US and are available 
from the University of Vermont (Goodell et al. 1986, Cun-
ningham et al. 2000, DeCoster and Bozorgnia 2008), as well 
as from Germany (Kelm et al. 2004). 
Surgeons should be aware that beads or spacers that they 
make themselves must have good pharmacokinetic properties 
to be effective, and that not all kinds of antibiotics may be 
released properly from bone cement. With the special tech-
nique for improvement of antibiotic release properties of bone 
cement described in the article of Neut et al., and the use of a 
mold, it is now possible for the surgeon to make customized 
antibiotic-loaded PMMA beads with different antibiotics and 
with an improved antibiotic release. We will need this tech-
nique increasingly for prosthetic joint infections and osteomy-
elitis, since resistant bacteria such as CNS, MRSE and MRSA 
are becoming ever more frequent. It is remarkable that the 
scientific help of a western university (Groningen) to solve a 
problem in a developing country may improve the treatment 
of bone and joint infections in many centres in the western 
world itself.
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